You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CNS tumors

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MRI Gadopiclenol Enhanced Imaging of CNS Tumors

Not yet recruiting
  • Image
  • (no location specified)
Nov 8, 2023

CNS Germinoma, CNS Tumor, Asian Consortium Trial in Goyang-si (Radiation Therapy)

Recruiting
  • CNS Germinoma
  • +2 more
  • Radiation Therapy
  • Goyang-si, Gyeonggi-do, Korea, Republic of
    National Cancer Center, Korea
Aug 7, 2023

Artificial Intelligence in CNS Radiation Oncology

Not yet recruiting
  • CNS Tumor
  • The images (CT, MRI, PET) used for RT planning, mid-treatment imaging as part of IGRT or disease evaluation, and response assessment/ surveillance post-RT
  • (no location specified)
Sep 6, 2023

CNS Tumors, Atypical Teratoid/Rhabdoid Tumor, Diffuse Midline Glioma, H3 K27M-Mutant Trial in Memphis (B7-H3-CAR T cells)

Not yet recruiting
  • Central Nervous System Neoplasms
  • +6 more
  • B7-H3-CAR T cells
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Apr 18, 2023

68-Ga DOTATATE PET/MRI in Diagnosis and Management of

Recruiting
  • CNS Tumors
  • +6 more
  • Ga68-DOTATATE-PET/MRI
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2022

Brain Slice Explants to Predict Drug Response in Brain Tumors

Not yet recruiting
  • Central Nervous System Tumor
  • Biospecimen collection
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jul 28, 2023

Rare CNS Tumors Outcomes &Risk

Recruiting
  • High Grade Meningioma
  • +4 more
    • Bethesda, Maryland
      National Cancer Institute (NCI)
    Jul 6, 2022

    Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)

    Recruiting
    • Ewing's Family Tumors
    • +11 more
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Apr 11, 2022

    Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor of CNS Trial in Memphis (Idasanutlin,

    Not yet recruiting
    • Rhabdoid Tumor
    • +3 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jul 11, 2023

    Refractory Cancer, CNS Tumors, CNS Tumor, Adult Trial in Atlanta, New York (Avutometinib)

    Recruiting
    • Refractory Cancer
    • +14 more
    • Atlanta, Georgia
    • +1 more
    Oct 23, 2023

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (EGFR806-specific chimeric antigen receptor (CAR) T cell)

    Active, not recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • EGFR806-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Jan 18, 2023

    CNS Tumor, Pediatric, Glioma, Ependymoma Trial in Seattle (HER2-specific chimeric antigen receptor (CAR) T cell)

    Recruiting
    • Central Nervous System Tumor, Pediatric
    • +8 more
    • HER2-specific chimeric antigen receptor (CAR) T cell
    • Seattle, Washington
      Seattle Children's Hospital
    Dec 14, 2022

    Diffuse Midline Glioma (DMG), Glioblastoma, Recurrent Ependymoma Trial in San Francisco, Ann Arbor, Zürich (ONC206, Standard of

    Recruiting
    • Diffuse Midline Glioma (DMG)
    • +7 more
    • ONC206
    • Standard of Care Radiation Therapy
    • San Francisco, California
    • +2 more
    Sep 13, 2022

    Three-Factor Eating Questionnaire in Measuring Eating Behavior

    Completed
    • Cancer Survivor
    • Nutritional Assessment
    • Questionnaire Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 1, 2022

    CNS Tumors Trial in Worldwide (Avelumab, Lenvatinib)

    Recruiting
    • Central Nervous System Tumors
    • Saint Louis, Missouri
    • +9 more
    Jul 21, 2022

    Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

    Not yet recruiting
    • Anaplastic Astrocytoma
    • +17 more
      • (no location specified)
      Jun 28, 2023

      ALK Fusion-positive Solid or CNS Tumors Trial in Worldwide (Alectinib)

      Recruiting
      • ALK Fusion-positive Solid or CNS Tumors
      • New York, New York
      • +17 more
      Jul 25, 2022

      Advanced Non CNS Tumors Trial in Worldwide (Talimogene Laherparepvec)

      Completed
      • Advanced Non CNS Tumors
      • Talimogene Laherparepvec
      • Wilmington, Delaware
      • +21 more
      Dec 21, 2022

      Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

      Not yet recruiting
      • Diffuse Intrinsic Pontine Glioma
      • +4 more
      • SC-CAR4BRAIN
      • Seattle, Washington
        Seattle Children's Hospital
      Mar 3, 2023

      CNS Qualitative Interview

      Recruiting
      • Central Nervous System Cancer
      • Qualitative Interviews
      • Aurora, Colorado
        Children's Hospital Colorado
      Oct 31, 2022

      Advanced Solid Tumor, CNS Tumor, Recurrent WHO Grade II Glioma Trial in Canada, Germany, United States (Infigratinib)

      Not yet recruiting
      • Advanced Solid Tumor
      • +2 more
      • Palo Alto, California
      • +9 more
      Aug 2, 2022

      Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)

      Recruiting
      • Ewing Sarcoma
      • +5 more
      • Valhalla, New York
        New York Medical College
      Oct 24, 2022

      Germ Cell Tumors of the Central Nervous System

      Recruiting
      • Germ Cell Tumor of CNS
        • Beijing, China
          Sanbo Brain Hospital Capital Medical University
        Apr 19, 2023

        Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

        Recruiting
        • Atypical Teratoid Rhabdoid Tumor
        • +6 more
        • Boston, Massachusetts
        • +1 more
        Jan 23, 2023

        Brain Tumor, Recurrent, Brain Tumor, Refractory Trial in Houston (HER2-specific T cells)

        Recruiting
        • Brain Tumor, Recurrent
        • Brain Tumor, Refractory
        • HER2-specific T cells
        • Houston, Texas
        • +1 more
        May 3, 2022